Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:37:14 EST Fri 06 Feb 2026
Enter Symbol
or Name
USA
CA



Z:GSK - GSK PLC SPON ADS EACH REP 2 ORD SHS - https://www.gsk.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GSK - Z1.055.00·60.500.860.23+1.0771.88,149.1483,18742,98559.29  60.37  59.2559.615  32.3819:51:00Jan 2115 min RT 2¢

Recent Trades - Last 10 of 42985
Time ETExPriceChangeVolume
19:51:00Z60.020.8517
19:48:56Z60.12250.952512
19:44:30Z60.12250.95252
19:25:40Z59.98470.814750
19:22:27Z60.050.885
19:21:50Z60.000.8310
19:20:31Z60.000.8310
19:18:01Z60.000.8310
19:08:15Z60.12250.952520
18:10:42Z60.601.431

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-21 10:00U:GSKNews ReleaseGSK Awards $2M in COiMMUNITY Initiative Grants to Help Close Vaccination Gaps, Commits $3M for 2026
2026-01-20 09:00U:GSKNews ReleaseGSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
2025-12-16 21:55U:GSKNews ReleaseExdensur (depemokimab) approved by US FDA for the treatment of severe asthma
2025-10-23 20:11U:GSKNews ReleaseBlenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
2025-10-21 02:00U:GSKNews ReleasePIVOT-PO Phase 3 Data Show Tebipenem HBr's Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
2025-10-01 10:00U:GSKNews ReleaseNew Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level
2025-07-24 09:00U:GSKNews ReleaseGSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
2025-07-17 07:00U:GSKNews ReleaseUS FDA Approves GSK's SHINGRIX in a Prefilled Syringe Presentation
2025-07-10 09:13U:GSKNews ReleaseGSK begins shipping influenza vaccine doses for the 2025-26 flu season
2025-06-24 09:00U:GSKNews ReleaseFDA approves Benlysta (belimumab) Autoinjector for children with active lupus nephritis
2025-06-16 09:33U:GSKNews ReleaseGSK announces the Linked by Lupus: Optimal Care Initiative to help support individuals with lupus in the US
2025-06-02 06:00U:GSKNews ReleaseTheravance Biopharma, Inc. Sells Remaining Royalty Interest in Trelegy Ellipta to GSK for $225 Million
2025-05-28 07:00U:GSKNews ReleaseSpero Therapeutics and GSK Announce PIVOT-PO Phase 3 Study for Tebipenem HBr Stopped Early for Efficacy Following Review by Independent Data Monitoring Committee
2025-05-22 16:15U:GSKNews ReleaseNucala (mepolizumab) approved by US FDA for use in adults with chronic obstructive pulmonary disease (COPD)
2025-05-09 09:00U:GSKNews ReleaseGSK and Lifetime(TM) launch original movie to raise awareness about the impact of meningitis
2025-04-17 08:00U:GSKNews ReleaseAlector Announces Completion of Enrollment in the PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Individuals with Early Alzheimer's Disease
2025-04-16 17:36U:GSKNews ReleaseAREXVY recommended for adults aged 50-59 at increased risk for severe respiratory syncytial virus (RSV) disease by US Advisory Committee on Immunization Practices
2025-04-16 16:57U:GSKNews ReleaseGSK's 5-in-1 Meningococcal Vaccine PENMENVY Receives Positive Recommendation from US Advisory Committee on Immunization Practices
2025-04-09 10:00U:GSKNews ReleaseGSK Awards $2M in Grant Funding for Programs Supporting Adult Vaccination, Commits Additional $2M for 2025
2025-03-25 18:15U:GSKNews ReleaseBlujepa (gepotidacin) Approved by US FDA for Treatment of Uncomplicated Urinary Tract Infections (uUTIs) in Female Adults and Pediatric Patients 12 Years of Age and Older